Pierre Fabre Laboratories Announces Global Partnership with Know Your Lemons Foundation for Breast Cancer Awareness Month
Innovative Campaign Focuses on Early Detection and Empowering Education Throughout October CASTRES,…
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug…
Vertical AI acquires equity stake in Levangie Labs to supercharge platform capabilities
WILLEMSTAD, Curaçao, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Vertical AI, is a…
SmartVascular Dx Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL”…
96% of health care executives are “ready and resourced” to use digital health solutions, yet two-thirds say interoperability is “a tough but manageable challenge,” reveals new MIT Technology Review Insights report
CAMBRIDGE, Mass., June 25, 2025 /PRNewswire/ -- A new survey report by MIT…
Expanding Access in California: SmartVascular Dx Test Now Available Through Major Health Plans
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL”…
Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241
PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed…